Guidelines - ICH
|
CPMP/ICH/379/95 - Note for Guidance on Studies in Support of Special Populations: Geriatrics
CPMP/ICH/378/95 - Note for Guidance on Dose Response Information to Support Drug Registration
CPMP/ICH/377/95 - Note for Guidance on Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
CPMP/ICH/375/95 - Note for Guidance on Population Exposure: The Extent of Population Exposure to Assess Clinical Safety
CPMP/ICH/364/96 - Note for Guidance on Choice of Control Group in Clinical Trials
CPMP/ICH/363/96 - Note for Guidance on Statistical Principles for Clinical Trials
CPMP/ICH/302/95 - Note for Guidance on Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
CPMP/ICH/291/95 - Note for Guidance on General Considerations for Clinical Trials
CPMP/ICH/289/95 - Note for Guidance on Ethical Factors in the Acceptability of Foreign Clinical Data
CPMP/ICH/288/95 - Note for Guidance on Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
CPMP/ICH/287/95 - Note for Guidance on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports
CPMP/ICH/286/95 - Note for Guidance on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals
CPMP/ICH/137/95 - Note for Guidance on Structure and Content of Clinical Study Reports
CPMP/ICH/135/95 - Note for Guidance on Good Clinical Practice
|
 |
